JP2015504438A5 - - Google Patents

Download PDF

Info

Publication number
JP2015504438A5
JP2015504438A5 JP2014542858A JP2014542858A JP2015504438A5 JP 2015504438 A5 JP2015504438 A5 JP 2015504438A5 JP 2014542858 A JP2014542858 A JP 2014542858A JP 2014542858 A JP2014542858 A JP 2014542858A JP 2015504438 A5 JP2015504438 A5 JP 2015504438A5
Authority
JP
Japan
Prior art keywords
oligonucleotide
use according
composition
administered
weeks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014542858A
Other languages
English (en)
Japanese (ja)
Other versions
JP6193248B2 (ja
JP2015504438A (ja
Filing date
Publication date
Priority claimed from EP11190826.5A external-priority patent/EP2596806A1/en
Application filed filed Critical
Publication of JP2015504438A publication Critical patent/JP2015504438A/ja
Publication of JP2015504438A5 publication Critical patent/JP2015504438A5/ja
Application granted granted Critical
Publication of JP6193248B2 publication Critical patent/JP6193248B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014542858A 2011-11-25 2012-11-23 結腸切除の予防のための方法 Expired - Fee Related JP6193248B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP11190826.5A EP2596806A1 (en) 2011-11-25 2011-11-25 Method for prevention of colectomy
EP11190826.5 2011-11-25
US201261595230P 2012-02-06 2012-02-06
US61/595,230 2012-02-06
PCT/EP2012/073501 WO2013076262A1 (en) 2011-11-25 2012-11-23 Method for prevention of colectomy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016218270A Division JP6318221B2 (ja) 2011-11-25 2016-11-08 結腸切除の予防のための方法

Publications (3)

Publication Number Publication Date
JP2015504438A JP2015504438A (ja) 2015-02-12
JP2015504438A5 true JP2015504438A5 (enExample) 2016-01-28
JP6193248B2 JP6193248B2 (ja) 2017-09-06

Family

ID=45094516

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014542858A Expired - Fee Related JP6193248B2 (ja) 2011-11-25 2012-11-23 結腸切除の予防のための方法
JP2016218270A Expired - Fee Related JP6318221B2 (ja) 2011-11-25 2016-11-08 結腸切除の予防のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016218270A Expired - Fee Related JP6318221B2 (ja) 2011-11-25 2016-11-08 結腸切除の予防のための方法

Country Status (16)

Country Link
US (3) US9492516B2 (enExample)
EP (3) EP2596806A1 (enExample)
JP (2) JP6193248B2 (enExample)
CA (1) CA2892203C (enExample)
CY (1) CY1122089T1 (enExample)
DK (1) DK2782602T3 (enExample)
ES (1) ES2745677T3 (enExample)
HR (1) HRP20191723T1 (enExample)
HU (1) HUE046154T2 (enExample)
LT (1) LT2782602T (enExample)
PL (1) PL2782602T3 (enExample)
PT (1) PT2782602T (enExample)
RS (1) RS59358B1 (enExample)
SI (1) SI2782602T1 (enExample)
SM (1) SMT201900527T1 (enExample)
WO (1) WO2013076262A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102040448B1 (ko) * 2013-07-05 2019-11-04 새턴 라이센싱 엘엘씨 송신 장치 및 송신 방법, 및 수신 장치 및 수신 방법
WO2018102397A1 (en) 2016-11-29 2018-06-07 PureTech Health LLC Exosomes for delivery of therapeutic agents
CA3058966A1 (en) 2017-04-14 2018-10-18 Tollnine, Inc. Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their use
GB201707501D0 (en) * 2017-05-10 2017-06-21 Index Pharmaceuticals Ab New therapy 2
GB201707503D0 (en) * 2017-05-10 2017-06-21 Index Pharmaceuticals Ab New Therapy 3
GB201807312D0 (en) * 2018-05-03 2018-06-20 Index Pharmaceuticals Ab Formulation
GB201818579D0 (en) * 2018-11-14 2018-12-26 Index Pharmaceuticals Ab New therapy
GB201912191D0 (en) * 2019-08-24 2019-10-09 Index Pharmaceuticals Ab New therapy
EP4147688A1 (en) * 2021-09-09 2023-03-15 InDex Pharmaceuticals AB Enema formulation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149797A (en) 1990-02-15 1992-09-22 The Worcester Foundation For Experimental Biology Method of site-specific alteration of rna and production of encoded polypeptides
EP0468520A3 (en) 1990-07-27 1992-07-01 Mitsui Toatsu Chemicals, Inc. Immunostimulatory remedies containing palindromic dna sequences
US5849719A (en) 1993-08-26 1998-12-15 The Regents Of The University Of California Method for treating allergic lung disease
DE69535905D1 (de) 1994-07-15 2009-02-26 Coley Pharm Group Inc Immunomodulatorische Oligonukleotide
CA2244946C (en) 1996-01-30 2010-04-13 The Regents Of The University Of California Gene expression vectors which generate an antigen specific immune response and methods of using the same
EP0930893B1 (en) 1996-10-11 2005-04-13 The Regents of The University of California Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
US6426334B1 (en) 1997-04-30 2002-07-30 Hybridon, Inc. Oligonucleotide mediated specific cytokine induction and reduction of tumor growth in a mammal
WO1998052581A1 (en) 1997-05-20 1998-11-26 Ottawa Civic Hospital Loeb Research Institute Vectors and methods for immunization or therapeutic protocols
US6809193B2 (en) * 1997-08-13 2004-10-26 Isis Pharmaceuticals, Inc. Antisense oligonucleotide compositions and methods for the modulation of JNK proteins
WO2006075254A2 (en) 2005-01-13 2006-07-20 Progenika Biopharma, S.A. Methods and products for in vitro genotyping
WO2006132204A1 (ja) 2005-06-06 2006-12-14 Anges Mg, Inc. 転写因子デコイ
PL2380584T3 (pl) 2005-07-01 2014-03-31 Index Pharmaceuticals Ab Sposób do immunostymulacji
ES2330884T3 (es) 2005-07-01 2009-12-16 Index Pharmaceuticals Ab Modulacion de la respuesta a los esteroides.
JP5746038B2 (ja) 2008-11-04 2015-07-08 インデックス・ファーマシューティカルズ・アクチエボラーグ Cnsの炎症性疾患の治療のための化合物および方法

Similar Documents

Publication Publication Date Title
JP2015504438A5 (enExample)
HRP20191723T1 (hr) Nukleotid dims0-150 za primjenu u liječenju kroničnog aktivnog ulceroznog kolitisa
JP2016074736A5 (enExample)
NZ625592A (en) Compositions and methods for the treatment of hepatic diseases and disorders
JP2016502858A5 (enExample)
JP2015514418A5 (enExample)
IL317818A (en) Oligonucleotides to reduce PD-L1 expression
JP2014513954A5 (enExample)
JP2016195616A5 (enExample)
JP2018110601A5 (enExample)
JP2012516856A5 (enExample)
JP2017505623A5 (enExample)
JP2014532704A5 (enExample)
MY161593A (en) Oral formulations of cytidine analogs and methods of use thereof
JP2014504857A5 (enExample)
JP2013067645A5 (enExample)
HK1200716A1 (zh) 使用胞苷類似物的口服製劑治療癌症的方法
ME02321B (me) Antivirusna jedinjenja
JP2013518107A5 (enExample)
JP2016116520A5 (enExample)
JP2016508134A5 (enExample)
MX359548B (es) Agentes de iarn modificados.
JP2020522244A5 (enExample)
JP2017521433A5 (enExample)
AR084319A1 (es) INHIBIDORES DE microARN (miARN O miR) QUE COMPRENDEN NUCLEOTIDOS BLOQUEADOS